Novartis AG (NVS) Shareholder Equity
- 2025-12-31: Noncontrolling Interest In Acquiree Recognised At Acquisition DateUSD (m); Noncontrolling InterestsUSD $419.00M.
- 2025-06-30: Noncontrolling Interest In Acquiree Recognised At Acquisition DateUSD (m); Noncontrolling InterestsUSD $69.00M.
- 2024-12-31: Noncontrolling Interest In Acquiree Recognised At Acquisition DateUSD $75.00M; Noncontrolling InterestsUSD $80.00M.
- 2024-06-30: Noncontrolling Interest In Acquiree Recognised At Acquisition DateUSD $108.00M; Noncontrolling InterestsUSD $169.00M.
Novartis AG Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Noncontrolling Interest In Acquiree Recognised At Acquisition Date USD | Noncontrolling Interests USD |
|---|---|---|
| 2025-12-31 | (m) | $419.00M |
| 2025-06-30 | (m) | $69.00M |
| 2024-12-31 | $75.00M | $80.00M |
| 2024-06-30 | $108.00M | $169.00M |
| 2023-12-31 | (m) | $83.00M |
| 2023-06-30 | (m) | $84.00M |
| 2022-12-31 | (m) | $81.00M |
| 2022-06-30 | (m) | $81.00M |
| 2021-12-31 | $105.00M | $167.00M |
| 2021-06-30 | $22.00M | $86.00M |
| 2020-12-31 | (m) | $68.00M |
| 2020-06-30 | (m) | $73.00M |
| 2019-12-31 | (m) | $77.00M |
| 2019-06-30 | (m) | $78.00M |
| 2018-12-31 | $26.00M | $78.00M |
| 2018-06-30 | (m) | $86.00M |
| 2017-12-31 | (m) | $59.00M |
| 2016-12-31 | (m) | $59.00M |